HK1104035A1 - Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same - Google Patents

Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same

Info

Publication number
HK1104035A1
HK1104035A1 HK07108597.3A HK07108597A HK1104035A1 HK 1104035 A1 HK1104035 A1 HK 1104035A1 HK 07108597 A HK07108597 A HK 07108597A HK 1104035 A1 HK1104035 A1 HK 1104035A1
Authority
HK
Hong Kong
Prior art keywords
same
pharmaceutical composition
composition containing
preparing
strontium hydrate
Prior art date
Application number
HK07108597.3A
Other languages
English (en)
Inventor
Tae Hee Ha
Hee Sook Oh
Won Jeoung Kim
Chang Hee Park
Eun Young Kim
Young Hoon Kim
Kwee Hyun Suh
Gwan Sun Lee
Original Assignee
Hanmi Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Science Co Ltd filed Critical Hanmi Science Co Ltd
Publication of HK1104035A1 publication Critical patent/HK1104035A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07108597.3A 2005-10-26 2007-08-07 Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same HK1104035A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20050101059 2005-10-26

Publications (1)

Publication Number Publication Date
HK1104035A1 true HK1104035A1 (en) 2008-01-04

Family

ID=37872502

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07108597.3A HK1104035A1 (en) 2005-10-26 2007-08-07 Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same

Country Status (10)

Country Link
US (4) US7576219B2 (es)
EP (2) EP2269999B1 (es)
KR (2) KR100818753B1 (es)
CN (1) CN101296921B (es)
BR (1) BRPI0617879A2 (es)
ES (1) ES2390848T3 (es)
HK (1) HK1104035A1 (es)
NZ (1) NZ568412A (es)
UA (1) UA86335C2 (es)
ZA (1) ZA200804492B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) * 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
WO2009074997A2 (en) * 2007-12-10 2009-06-18 Lee Pharma Ltd. A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate
CN102887885B (zh) * 2012-09-26 2014-12-10 江苏正大丰海制药有限公司 一种埃索美拉唑钠的制备方法
CN102964335B (zh) * 2012-11-13 2014-06-25 凌元敏 一种埃索美拉唑钠化合物及其制备方法和用途
CN103044400A (zh) * 2012-12-21 2013-04-17 北京华禧联合科技发展有限公司 埃索美拉唑镁盐及其制备方法
CN105853419B (zh) * 2016-06-10 2018-11-20 江苏食品药品职业技术学院 一种用于胃溃疡治疗的药物组合物及其应用
CN107773529B (zh) * 2016-08-24 2020-06-16 华仁药业股份有限公司 一种埃索美拉唑钠氯化钠注射液及其制备方法
CN110526899A (zh) * 2018-05-24 2019-12-03 刘力 埃索美拉唑锶新化合物及其药物组合物和用途
KR102197144B1 (ko) 2019-03-29 2021-01-05 유한회사 더프라임솔루션 아킹현상을 방지하는 저온 플라즈마 배출가스 입자상 물질 저감 장치
KR102249552B1 (ko) 2020-06-16 2021-05-12 (주)에미션컨트롤스탠다드 저온 플라즈마를 이용한 실내외 대기 중 또는 배출가스 내 오염물질 저감장치

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
DE60314105T2 (de) 2002-03-05 2008-01-24 Astrazeneca Ab Alkylammoniumsalze von omeprazol und esomeprazol
WO2004099182A1 (en) 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
SI1651217T1 (sl) 2003-07-23 2008-08-31 Nycomed Gmbh Alkalne soli inhibitorjev protonske ÄŤrpalke
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
KR100598261B1 (ko) 2003-12-30 2006-07-07 동부일렉트로닉스 주식회사 노광기의 웨이퍼 외곽 포커싱 장치
KR20080007508A (ko) 2005-05-06 2008-01-21 그렌마크 파머수티칼스 엘티디. 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물
US7576219B2 (en) * 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
JP5017274B2 (ja) 2005-10-26 2012-09-05 ハンミ・サイエンス・カンパニー・リミテッド Ｓ−オメプラゾールストロンチウム塩またはその水和物、その製造方法、及びこれを含む医薬組成物

Also Published As

Publication number Publication date
CN101296921A (zh) 2008-10-29
US20090258908A1 (en) 2009-10-15
ZA200804492B (en) 2009-08-26
EP2269999A1 (en) 2011-01-05
US20070093533A1 (en) 2007-04-26
US20110046383A1 (en) 2011-02-24
EP2269999B1 (en) 2016-03-02
US8586752B1 (en) 2013-11-19
US8106076B2 (en) 2012-01-31
ES2390848T3 (es) 2012-11-19
EP1780207A2 (en) 2007-05-02
BRPI0617879A2 (pt) 2011-08-09
EP1780207B1 (en) 2012-08-15
KR20080015483A (ko) 2008-02-19
CN101296921B (zh) 2012-07-18
NZ568412A (en) 2010-11-26
UA86335C2 (uk) 2009-04-10
US8513426B2 (en) 2013-08-20
US7576219B2 (en) 2009-08-18
US20130303772A1 (en) 2013-11-14
EP1780207A3 (en) 2007-07-04
KR20070045101A (ko) 2007-05-02
KR100818753B1 (ko) 2008-04-01

Similar Documents

Publication Publication Date Title
HK1104035A1 (en) Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same
WO2006104826A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2007087548A3 (en) Chemical compounds
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
EE04279B1 (et) Omeprasooli kristalne vorm
WO2007111864A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2007136577A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
TN2009000111A1 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2006057922A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
ATE504570T1 (de) Tartratsalz aus isofagomin und verwendungsverfahren dafür
NO20092398L (no) Krystallinske former av solvatisert ilaprazol
WO2007120575A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2008051403A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
PL2229938T3 (pl) Kompozycje ezetymibu
WO2007109799A3 (en) Polymorphs of eszopiclone malate
WO2007075749A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2009121535A3 (en) Antiproliferative compounds and therapeutic uses thereof
WO2007129066A8 (en) 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
NO20080037L (no) Kombinasjon av pyrimidylaminobenzamidforbindelser og imatinib for behandling eller forbyggelse av proliferative sykdommer
MY140986A (en) S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
WO2005085240A3 (en) Process for the preparation of ziprasidone
WO2004055001A3 (en) Rabeprazole calcium
MXPA05009183A (es) Polimorfos de s-omeprazol.
TW200637867A (en) Cefcapene pivoxil methanesulfonic acid salt

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170628